The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages
Abstract NLRP3 inflammasome is a vital player in macrophages pyroptosis, which is a type of proinflammatory cell-death and takes part in the pathogenesis of atherosclerosis. In this study, we used apoE−/− mice and ox-LDL induced THP-1 derived macrophages to explore the mechanisms of MCC950, a select...
Guardado en:
Autores principales: | Wenyun Zeng, Danbin Wu, Yingxin Sun, Yanrong Suo, Qun Yu, Miao Zeng, Qing Gao, Bin Yu, Xijuan Jiang, Yijing Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a1a3fc72dc24f0eba4dabdfe74bc59d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MCC950, the NLRP3 Inhibitor, Protects against Cartilage Degradation in a Mouse Model of Osteoarthritis
por: Bowei Ni, et al.
Publicado: (2021) -
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
por: Zhang C, et al.
Publicado: (2019) -
MCC950 Ameliorates Acute Liver Injury Through Modulating Macrophage Polarization and Myeloid-Derived Suppressor Cells Function
por: Wei Yan, et al.
Publicado: (2021) -
MCC Regulator of WNT Signaling Pathway (MCC) Is a Podocyte Essential Gene
por: Hui Song, et al.
Publicado: (2021) -
Rh-CXCL-12 Attenuates Neuronal Pyroptosis after Subarachnoid Hemorrhage in Rats via Regulating the CXCR4/NLRP1 Pathway
por: Ran Gu, et al.
Publicado: (2021)